BASILEA PHARMACEUTIC

BSLN
Delayed Swiss Exchange - 11:30 2022-12-05 am EST
49.25 CHF -0.20%

Turn to zoom
Prev.49.25000000
Open49.40000000
High50.10000000
Low49.15000000
Volume57 295
Latest news
11/24
11/02
11/02
11/02
Chart BASILEA PHARMACEUTICA AG
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance49,849,849,4
Spread/Res.-1,0%-1,0%-0,20%
Spread/Supp.4,9%30%27%
Support47,038,038,7
Financials
Sales 2022 116 M 123 M 123 M
Net income 2022 -21,3 M -22,6 M -22,6 M
Net Debt 2022 98,1 M 104 M 104 M
P/E ratio 2022 -26,9x
Yield 2022 -
Capitalization 587 M 624 M 624 M
EV / Sales 2022 5,91x
EV / Sales 2023 4,77x
Nbr of Employees 177
Free-Float 88,1%
Company
Basilea Pharmaceutica AG is a Switzerland-based commercial-stage biopharmaceutical company. The Company operates in one segment, which is the discovery, development, and commercialization of pharmaceutical products to meet the needs of patients with severe bacterial and fungal infections. It...
Sector :
Other Biotechnology & Medical Research
Calendar :
2023-02-21 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 49,25 CHF
Average target price 69,15 CHF
Spread / Average Target 40,4%